Therefore, our findings strongly suggest not only that aberrant Ca2+ entry could promote GC via Ca2+/AKT/β-catenin pathway, but also that calcium supplement and Hp infection are likely synergistic risk factors for GC pathogenesis. The gene discussed is AKT1; the disease is gastric cancer.